2190.HK
2190.HK
CNE100004JD2
ZYLOXTB
Loading chart...

Company Profile

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. The company's peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as covers hemodialysis access, arterial, venous, peripheral embolization intervention, and other intervention products. In addition, the company provides technical consultation and services, as well as imports materials. It serves patients and physicians. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.

Related stocks

301367.SZ
301367.SZ • China
BMC
46.71 CNY
875.66M USD 1Y -20.4%
1302.HK
1302.HK • China
LIFETECH SCI
1.35 HKD
757.09M USD 1Y -36.9%
688626.SS
688626.SS • China
XIANGYU MEDICAL CO LTD
40.49 CNY
969.39M USD 1Y -22.7%
688575.SS
688575.SS • China
SHENZHEN YHLO BIOTECH CO LTD
10.46 CNY
894.36M USD 1Y -28.1%
2697.HK
2697.HK • China
TH MEDICAL-B
183 HKD
1.2B USD
300143.SZ
300143.SZ • China
INKON LIFE
7.95 CNY
1.16B USD 1Y -9%
300206.SZ
300206.SZ • China
EDAN
11.68 CNY
1.01B USD 1Y -4.1%
0853.HK
0853.HK • China
MICROPORT
6.08 HKD
1.48B USD 1Y -59%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
51.2% p.a.
Max Drawdown (5Y)
-79.3%
Sharpe Ratio (5Y)
-0.25
Beta Factor
0.33
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (51.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -79.3% in the extended horizon.
ende